{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:05:04Z","timestamp":1794747904141,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D301-21-P-12254"],"award-info":[{"award-number":["75D301-21-P-12254"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D301-23-C-18264"],"award-info":[{"award-number":["75D301-23-C-18264"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.lana.2025.101130","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T07:58:03Z","timestamp":1747295883000},"page":"101130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real-world cohort study"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey M.","family":"Kornowske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cami R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radica Z.","family":"Alicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenn B.","family":"Daratha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Neumiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meda E.","family":"Pavkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Kenrik","family":"Duru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne B.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith C.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lana.2025.101130_bib1","series-title":"Type 1 diabetes estimates in children and adults","year":"2022"},{"key":"10.1016\/j.lana.2025.101130_bib2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.lana.2025.101130_bib3","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/dc18-0679","article-title":"Development of microvascular complications and effect of concurrent risk factors in type 1 diabetes: a multistate model from an observational clinical cohort study","volume":"41","author":"Bjerg","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2025.101130_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MNH.0000000000000688","article-title":"Disparities in chronic kidney disease-the state of the evidence","volume":"30","author":"Clark-Cutaia","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.lana.2025.101130_bib5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2337\/dc20-2839","article-title":"Cardiovascular and renal disease burden in type 1 compared with type 2 diabetes: a two-country nationwide observational study","volume":"44","author":"Krist\u00f3fi","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2025.101130_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ajkd.2020.11.026","article-title":"CKD progression and mortality among men and women: a nationwide study in Sweden","volume":"78","author":"Swartling","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lana.2025.101130_bib7","article-title":"The prevalence of chronic kidney disease and albuminuria in patients with type 1 and type 2 diabetes attending a single Centre","volume":"14","author":"Majeed","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.lana.2025.101130_bib8","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/dc24-0335","article-title":"Prevalence of chronic kidney disease in type 1 diabetes among adults in the U.S.","volume":"47","author":"Rossing","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2025.101130_bib9","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American diabetes association (ADA) and kidney disease: Improving global outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.lana.2025.101130_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Kidney Disease","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.lana.2025.101130_bib11","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"Improving global outcomes (KDIGO) CKD work group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.lana.2025.101130_bib12","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.2337\/dc24-S011","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2025.101130_bib13","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dci23-0030","article-title":"Diabetic nephropathy: update on pillars of therapy slowing progression","volume":"46","author":"Naaman","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2025.101130_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lana.2025.101130_bib15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12882-019-1558-9","article-title":"Rationale and design of a multicenter chronic kidney disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD","volume":"20","author":"Norris","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.lana.2025.101130_bib16","doi-asserted-by":"crossref","first-page":"e1918169","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD registry","volume":"2","author":"Tuttle","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lana.2025.101130_bib17","first-page":"2219","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"383","author":"Inker","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lana.2025.101130_bib18","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/archinternmed.2011.537","article-title":"Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study","volume":"171","author":"Shurraw","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lana.2025.101130_bib19","series-title":"2024 USRDS annual data report: Epidemiology of kidney disease in the United States. National institutes of health, national Institute of diabetes and digestive and kidney diseases, Bethesda, MD","year":"2024"},{"key":"10.1016\/j.lana.2025.101130_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMc2207018","article-title":"Incidence of chronic kidney disease among adults with diabetes, 2015\u20132020","volume":"387","author":"Tuttle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lana.2025.101130_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.ajkd.2017.09.017","article-title":"Population health for CKD and diabetes: lessons from the Indian Health Service","volume":"71","author":"Narva","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.lana.2025.101130_bib22","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1210\/jc.2019-00734","article-title":"Longitudinal phenotypes of type 1 diabetes in youth based on weight and glycemia and their association with complications","volume":"104","author":"Kahkoska","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lana.2025.101130_bib23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2337\/dc13-2113","article-title":"Kidney disease and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"de Boer","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.lana.2025.101130_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MNH.0000000000000212","article-title":"The dual roles of obesity in chronic kidney disease: a review of the current literature","volume":"25","author":"Rhee","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.lana.2025.101130_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MNH.0000000000000756","article-title":"Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease","volume":"31","author":"Rhee","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.lana.2025.101130_bib26","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1111\/dom.15194","article-title":"Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD registry, 2019\u20132020","volume":"25","author":"Nicholas","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.lana.2025.101130_bib27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s40620-022-01476-w","article-title":"Sustained employment, work disability and work functioning in CKD patients: a cross-sectional survey study","volume":"36","author":"Alma","year":"2023","journal-title":"J Nephrol"},{"key":"10.1016\/j.lana.2025.101130_bib28","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.lana.2025.101130_bib29","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lana.2025.101130_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lana.2025.101130_bib31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S2213-8587(23)00168-7","article-title":"People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action","volume":"11","author":"Heerspink","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.lana.2025.101130_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.kint.2022.09.020","article-title":"Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations","volume":"103","author":"Carrero","year":"2023","journal-title":"Kidney Int"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X25001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:17:17Z","timestamp":1778930237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X25001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"alternative-id":["S2667193X25001401"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2025.101130","relation":{},"ISSN":["2667-193X"],"issn-type":[{"value":"2667-193X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and severity of chronic kidney disease in a population with type 1 diabetes from a United States health system: a real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2025.101130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101130"}}